Showing 2101-2110 of 10490 results for "".
PRP: Assessing Its Safety and Efficacy
https://practicaldermatology.com/topics/practice-management/prp-assessing-its-safety-and-efficacy/20580/As use of platelet-rich plasma grows in popularity, a dermatologist undertakes a review of the current evidence.Keep the Insurance Profit, Reduce Taxes, Protect Assets: Own Your Own Insurance Company
https://practicaldermatology.com/topics/practice-management/keep-the-insurance-profit-reduce-taxes-protect-assets-own-your-own-insurance-company/21516/Empathy and Transactional Medicine: Improving Patient and Physician Outcomes
https://practicaldermatology.com/topics/skin-cancer-photoprotection/transactional-medicine-improving-patient-and-physician-outcomes/20316/For each individual patient, the patient-physician interaction is unique and requires vulnerability, exposure, and discomfort.New in My Practice: Device: Cutera’s AviClear
https://practicaldermatology.com/topics/acne-rosacea/new-in-my-practice-device-cuteras-aviclear/23738/Therapeutics Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/theraputics-update/20510/New products and pharmacologic developmentsWhat Your Patients Need to Hear About Sunscreens
https://practicaldermatology.com/topics/general-topics/what-your-patients-need-to-hear-about-sunscreens/20432/You can't fight every misperception, but you can arm patients with essential facts.Therapeutics Update: Notable Approvals in 2017
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-update-notable-approvals-in-2017/20398/A look at the newest additions to the medicine chest.Grant Opportunity
https://practicaldermatology.com/topics/practice-management/grant-opportunity/21207/Native American Health Service Resident Rotation ProgramThe Microbiome in Acne: Where are We Now?
https://practicaldermatology.com/topics/acne-rosacea/the-microbiome-in-acne-where-are-we-now/23731/As research reveals connections of the microbiome to skin disease, clinicians may discover new approaches to managing the disease.A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.